Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Barco

CONSOLIDATED RESULTS FOR FISCAL YEAR 2011

Sales and order intake

Sales in 2011 were 1,041.2 million euro, representing robust growth of 16.1% compared to the 897.0 million of 2010.

http://barco.com/en/investors/pressrelease/2875/

Share
New Message
Please login to post a reply